Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.
By not having Harper involved. This doesn't conflict with the oil sands so the Evil Harper Government doesn't care. Of course you could say someone's head should be rolling for allowing a government funded vaccine to be sold off to a US corp for a pittance (which is what the article is about).